News

Praxis Precision Medicines Outlines November Conference Engagements

Praxis Precision Medicines Outlines November Conference Engagements

Praxis Precision Medicines Announces November Conference Participation

BOSTON — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a dedicated clinical-stage biopharmaceutical company focused on advancing therapies for central nervous system (CNS) disorders, has shared its plans to engage in several prominent investor conferences this November. These conferences present a prime opportunity for the company's management to connect with investors, discuss its innovations, and shed light on its current projects aimed at addressing critical CNS issues.

Details of Conference Participation

Truist Securities BioPharma Symposium

One of the standout events will be at the Truist Securities BioPharma Symposium, where Praxis leadership will take part in a fireside chat scheduled for November 7. This chat will be held at the Lotte New York Palace Hotel in New York City, beginning at 9:40 AM ET. This event is anticipated to be a key touchpoint for exchanging ideas and insights into the biopharmaceutical landscape.

Guggenheim Securities Healthcare Innovation Conference

Subsequently, on November 11, Praxis management will also join the Guggenheim Securities Inaugural Healthcare Innovation Conference at the InterContinental in Boston. Starting at 1:00 PM ET, this fireside chat will delve into the innovative strides being made in the field. Investors interested in hearing the discussions can access a live webcast of this event through the company's investor relations platform.

Jefferies London Healthcare Conference

The third event on the agenda is the Jefferies London Healthcare Conference, taking place on November 20-21. Here, Praxis will engage in one-on-one meetings with potential investors, further fostering relationships to support its ongoing projects.

Investor Engagement and Q&A Opportunities

The Company encourages interested investors to reach out to their corporate access representatives to set up one-on-one meetings during the Truist and Guggenheim conferences. This initiative highlights Praxis's commitment to maintaining transparency and accessibility as it advances its portfolio.

Live Webcast Access and Availability

For those unable to attend in person, a live webcast of the fireside chat at the Guggenheim conference will be available through the “Upcoming & Recent Events” section on the company’s website. Additionally, following the event, a replay will be accessible on the Events and Presentations page for 90 days, allowing others to catch up on the insights shared.

About Praxis Precision Medicines

Praxis Precision Medicines operates as a vanguard in the field of biopharmaceuticals, leveraging genetic insights gained from the study of epilepsy to develop cutting-edge therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance. The company is dedicated to innovative breakthroughs through its proprietary platforms such as Cerebrum™ and Solidus™. These platforms enable the discovery and development of therapies aimed at both rare and widespread neurological conditions. Currently, Praxis boasts a diverse CNS portfolio, featuring multiple clinical-stage product candidates aimed at movement disorders and epilepsy.

Frequently Asked Questions

What is the purpose of Praxis Precision Medicines participating in these conferences?

The participation allows Praxis to connect with investors, discuss advancements in their projects, and showcase their innovative strategies for addressing CNS disorders.

When and where will the Truist Securities BioPharma Symposium be held?

The Truist Securities BioPharma Symposium is scheduled for November 7 at the Lotte New York Palace Hotel in New York City, beginning at 9:40 AM ET.

Will there be online access to the Guggenheim Healthcare Innovation Conference?

Yes, a live webcast of the Guggenheim fireside chat will be available on the company’s investor relations platform.

Which platforms does Praxis use for therapy development?

Praxis utilizes two proprietary platforms, Cerebrum™ for small molecule therapies and Solidus™ for antisense oligonucleotides (ASOs), to develop treatments for CNS disorders.

How can investors schedule one-on-one meetings with company management?

Investors interested in meetings should contact their corporate access representatives at the respective conferences to request appointments.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 217

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 183

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 304

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 201

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 274

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 308

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 214

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 162

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 175

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 411

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading

Top 5 Most Recently Viewed Articles

Hoymiles Shines at RE+ with Innovative Solar Solutions

Updated Category News Views 246

Hoymiles Unveils Exciting Innovations at RE+ The 2024 edition of RE+ was a major event where Hoymiles showcased its groundbreaking developments in power electronics, particularly focusing on photovoltaic (PV) systems and energy storage technologies. As a leader in this sector, the company drew in audiences with its cutting-edge microinverter solutions, crafted to address...

Continue Reading
Ageas Enhances Shareholder Value with Buy-Back Progress

Updated Category News Views 161

Ageas Advances Share Buy-Back Program Ageas has announced updates regarding its share buy-back program initiated on August 28, 2024. As part of this initiative, the company has successfully repurchased 38,549 of its shares between December 30, 2024, and January 3, 2025. This strategic move is part of Ageas's ongoing efforts to enhance shareholder value through the...

Continue Reading
Empowering Investigators: Genetec's Innovative Vehicle Data Tools

Updated Category News Views 220

Unlocking New Possibilities for Law Enforcement In a significant advancement for law enforcement capabilities, a leading technology provider announced innovative features designed to streamline the collection and sharing of vehicle data for investigations. The integration of these tools aims to enhance the speed and security of evidence handling, assisting detectives in...

Continue Reading
Cathay Cargo and Descartes Ensure Safe Panda Transport

Updated Category News Views 229

Enhancing Logistics: The Role of Technology in Cargo Transport In a remarkable effort to safeguard one of nature's most beloved creatures, Cathay Cargo, a prominent air freight service provider, collaborated with Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG). Utilizing Descartes’ innovative Bluetooth Low Energy tracking solution, they successfully monitored the safe...

Continue Reading
NB Private Equity Partners Enhances Shareholder Value Through Buyback

Updated Category News Views 150

Introduction to Recent Share Buyback Activity NB Private Equity Partners, often referred to as NBPE, has recently initiated a significant share buyback of its Class A Shares. This buyback aligns with the authority provided by shareholders and underscores the company’s commitment to enhancing shareholder value. Details of the Share Buyback The transaction has been made...

Continue Reading